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There is no doubt that endovascular aortic aneurysm
repair (EVAR) results in lower perioperative mortality
when compared with open aneurysm repair in elective,
nonruptured, patients. Multiple well-designed, large,
randomized controlled trials (RCTs) have consistently
shown a roughly 50% reduction in the risk of 30-day
mortality in favor of endovascular repair for elective
abdominal aortic aneurysms (AAAs).1e3 Given the
increased mortality associated with open repair of
ruptured AAAs (rAAAs), many surgeons and investigators
expected to see a similar improvement in mortality
when EVAR was compared with open repair (OR) in this
high-risk patient group. The observational literature has
indeed shown such an improvement, with reported
mortality rates following EVAR ranging from 16% to 35%
compared with 37e63% following OR.4e14 This differ-
ence in mortality has been further substantiated by
large administrative database studies,15e17 the largest of
which included data on >42,000 patients and reported areduced in-hospital mortality rate associated with EVAR
in ruptured patients (26% vs. 39%; p < .001).17 With
the sheer volume of observational and administrative
data available indicating a reduction in perioperative
mortality, some authors have argued that randomized
trials comparing EVAR and OR are unnecessary and may
even be unethical.11,18
Many of the beneﬁts touted for EVAR in a patient with a
ruptured AAA seem self-evident: reduced physiologic stress
with avoidance of aortic cross clamping and ischemia-
reperfusion injury, the ability to carry out the procedure
under local anesthetic, reduced hypothermia, and reduced
blood loss. Yet despite these considerations and the weight
of the previous observational data, RCTs to date have
shown no difference in early mortality between EVAR and
OR in ruptured patients. Certainly, these results would seem
surprising to many surgeons; however, one cannot ignore
the evidence.
Two of the trials are smaller, and may be criticized for
being underpowered. The ﬁrst trial, from the UK, included
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was similar between OR and EVAR (53% in both groups).19
Similarly, in the Dutch trial that included the results of 116
patients, there was no difference in 30-day mortality be-
tween EVAR and OR (21% vs. 25%).20 The latter trial has
been criticized for being too selective as it excluded patients
who were either too unstable for computed tomography
(CT) scan or had anatomy unsuitable for EVAR. These criti-
cisms were addressed by the recent publication of early
results from the IMPROVE trial. This trial was not only larger
and more appropriately powered but was designed in a
pragmatic style that strove to include all patients who
presented to hospital with a suspected diagnosis of rAAA. In
doing so, the investigators ensured generalizability of their
results. The IMPROVE trial clearly demonstrated, based on
the analysis of 613 patients, that a nonselective approach to
EVAR in patients with rAAA resulted in equivalent 30-day
mortality when compared with OR (35.4% vs. 37.4%;
p ¼ .620).21 Some may criticize this trial for its pragmatic
design, where patients were randomized to a therapeutic
approach as opposed to a speciﬁc procedure. Patients were
randomized once a clinical diagnosis of suspected rAAA was
made, without knowledge of their anatomic suitability for
EVAR. If randomized to the EVAR strategy arm, patients
would undergo a CT scan to determine anatomic suitability
and, if suitable, would undergo EVAR; otherwise, they
would undergo open repair. This method of allocation
resulted in only 64% of those in the EVAR group being
anatomically suitable, and 13% of patients had a diagnosis
other than rAAA. These limitations where necessary con-
sequences of the pragmatic trial design, ultimately ensuring
that both treatment strategies were comparable and free of
selection bias and confounding.
All RCTs to date have shown no difference in mortality
between OR and EVAR in ruptured patients. How can there
be such a discrepancy between the RCT literature and
observational data?
WHY OBSERVATIONAL STUDIES ARE MISLEADING
Regardless of the number of observational studies showing
improved mortality with an EVAR, they all suffer from the
same inherent biases that tend to favor EVAR. The most
recent and complete meta-analysis of the observational
literature comparing EVAR and OR in ruptured patients
found that most studies suffered from severe selection
bias.22 The key factors determining why many surgeons in
these studies offer EVAR to ruptured patients (stable
enough to have imaging and favorable anatomy) are also
both strong independent predictors of postoperative mor-
tality. The effect of preoperative hemodynamic instability on
mortality from ruptured aneurysms is well known.23 This
inherently favors the EVAR group by restricting EVAR to
those patients that at baseline have stable blood pressure
and an improved survival. Similarly, in observational studies
patients with short aortic necks (<10 mm) and challenging
iliac anatomy (tortuosity, calciﬁcation) tended to have OR.These same anatomic factors that make EVAR unfavorable
also make OR more complex and increase perioperative
mortality. In a recent abstract using the IMPROVE data,
investigators noted that mortality was associated with the
aortic neck length in both the EVAR and OR groups. In those
patients with aortic necks between 5 and 9 mm the 30-day
mortality for EVAR was 63% (vs. 44% for OR), while in those
with aortic neck lengths >30 mm, mortality in both groups
was w25%.24 Other authors have also shown EVAR
anatomic suitability to be a strong independent predictor of
mortality following open repair of rAAA.25 In addition to the
effect of selection bias, the observational studies also suffer
from a lack of blinded outcome assessments, selective
reporting of results, and publication bias.22 Publication bias
may be particularly important as centers with poor results
following EVAR for ruptured patients would be unlikely to
publish those results. Even those authors that are strong
advocates for an aggressive “EVAR-ﬁrst” policy for rAAA
have admitted that many of the centers reporting their
results for rAAA limit the procedure to hemodynamically
stable patients or those with “contained” ruptures and that
“it is totally invalid to compare the lower procedural EVAR
mortality rates with those for open repair”.26 I would agree,
and state that the only valid comparison comes from
properly designed, powered, and reported RCTs like
IMPROVE.
Not only do administrative and clinical database studies
suffer from the same limitations, they are also compounded
by errors in diagnostic coding, missing data on key con-
founders (hypotension, level of consciousness, anatomy),
and lack of information on the volume and experience of
the surgeons performing the interventions.17,27 These limi-
tations further compromise the comparison between EVAR
and OR for rAAA.
Observational studies often overestimate the beneﬁt of
new interventions when compared with RCTs.28 The litera-
ture is ﬁlled with examples where RCTs have contradicted
the results of observational studies and tempered early
enthusiasm for new procedures. Classic examples from the
vascular literature include the disappointing results of
prosthetic bypasses for leg ischemia when compared with
vein grafts, as reported by Veith et al. in the 1980s,29 the
harmful effects of extracranialeintracranial arterial bypass
in patients with cerebrovascular disease,30 and the lack of
beneﬁt to preoperative coronary artery revascularization
prior to vascular surgery.31 Similar to these examples, the
mortality beneﬁt ascribed to EVAR in rAAA patients by
observational studies has not been conﬁrmed by RCTs.
Despite all of EVAR’s theoretical advantages and presumed
effectiveness based on uncontrolled data, it seems that
favorable anatomy, hemodynamic instability, and overall
patient health status exert a greater inﬂuence on post-
operative mortality in ruptured patients than the method of
repair.
It is evident that surgeons expected to ﬁnd a mortality
beneﬁt to EVAR in ruptured patients. The language used in
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wards this investigator bias: “The ﬁnding that mortality
rates were comparable in open and endovascular groups
was disappointing.”;19 however, the existing level I evi-
dence quite clearly shows that EVAR does not confer a
survival advantage to patients with ruptured aneurysms.
Misinterpreting this literature could lead to troubling con-
sequences for patient care.POTENTIAL CONSEQUENCES OF MISINTERPRETING THE
LITERATURE
Believing the existing level I evidence to be ﬂawed, and
continual subscription to the notion that EVAR confers a
signiﬁcant survival advantage to all patients with rAAA,
may have unintended consequences. Advocates of this
interpretation may subscribe to an “EVAR-only” policy of
rAAA repair. This would result in patients with challenging
anatomy undergoing attempted EVAR with potentially
disastrous consequences for patient care. In support of
this notion is the fact that all patients in the IMPROVE trial
that underwent conversion from EVAR to OR for anatomic
misjudgment died.21 Adherence to an aggressive EVAR
policy would not only have problematic short-term results,
but would also likely be plagued by poor long-term results
with a high risk of re-interventions as EVAR is applied to
those with poor anatomy. Data from elective repairs have
clearly shown an increase in endoleak and sac enlarge-
ment in those patients in whom EVAR is applied outside
the anatomic constraints of instructions for use,32,33 and
one, large, long-term study has found a relatively high re-
intervention rate (23.1%) for graft-related complications in
patients with a rAAA and treated with EVAR.11 Another
potential implication of an aggressive EVAR policy is the
application of the repair to those patients that are so
moribund as to not survive regardless of the treatment
strategy used. There will continue to be a subset of pa-
tients with ruptured aneurysms who make it to the hos-
pital, but are too unstable and moribund to tolerate either
EVAR or OR. Attempting a “futile” EVAR may result in
wasted healthcare resources. Although not examined in
the literature on rAAA, extrapolation from the EVAR-2
trial, in which patients who were deemed too high risk
for an elective OR and were randomized to conservative
care or EVAR, showed that there does exist a subset of
patients who are too ill to beneﬁt from EVAR, even in the
elective setting.34
An overemphasis on the perceived mortality beneﬁts of
EVAR in ruptured patients may result in too liberal an
application of the technique to those with unfavorable
anatomy or to those who are too moribund to survive
surgery. Both approaches could have negative repercussions
and result in increased re-interventions, patient mortality,
and healthcare costs.CONCLUSIONS
Although most observational and administrative database
studies suggest a reduction in mortality with EVAR for pa-
tients with a rAAA, RCTs have found equivalent early mor-
tality when compared with OR. The observational literature
suffers from selection bias, with EVAR generally reserved for
those with favorable anatomy and hemodynamic stability.
The IMPROVE trial has shown that EVAR results in a
reduced length of hospital stay and a higher proportion of
home discharges.21 These beneﬁts should be acknowledged
but a misinterpretation of the literature resulting in an
aggressive “EVAR-only” policy may lead to increased short-
and long-term morbidity and mortality if the procedure is
attempted in those with unfavorable anatomy. The level I
evidence suggests that the same care and attention that
goes into selecting anatomically and physiologically suitable
candidates for EVAR in the elective setting should also be
applied to the ruptured patient. If patients are found to be
poor anatomic candidates for EVAR, then they are likely
best served with an expeditious OR.
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